Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer.

BMC Cancer · 2020 · PMC7057666 · PMID 32131779

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

In terms of recurrence, multivariate analysis showed that BRCA1/2 mutation was a marginally significant prognostic factor (HR, 0.65; 95% CI, 0.40–1.04).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.